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EgyptAbstract Background: Gastro-esophageal reﬂux disease (GERD) is one of the most prevalent dis-
eases seen in western countries. The prevalence of GERD is lower in the Asian population and the
spectrum of the disease is mild. Data from Africa and the Middle East are sparse.
Aim: The aim of the study was to determine the prevalence, severity and risk factors of reﬂux
esophagitis (RE) among patients undergoing endoscopy in a secondary referral hospital in Egypt.
Materials and methods: This was a retrospective study. Data on patients presenting with gastro-
esophageal reﬂux symptoms (RS) and scheduled for upper gastrointestinal endoscopy between
January 2000 and January 2013 were collected.
Results: Four hundred and thirty-three patients were assessed. Two hundred and ﬁfty-four (59%)
were male. Ages ranged from 18 to 85 years, mean 45 ± 15 years. One hundred and forty-four
patients (33%) had a history of smoking, 120 (28%) were taking aspirin or non-steroidal anti-
inﬂammatory drugs and 8 (2%) were consuming alcohol. The duration of RS ranged from one
90 A. Gado et al.month to 20 years, mean 21 ± 30 months. One hundred and forty-six patients (34%) had the RS
daily, 70 (16%) classiﬁed RS as severe intensity and 99 (23%) had acid regurgitation.
One hundred and six patients (24%) were found to have RE. Ninety-eight of them (23%) showed
grade 1. Barrett’s esophagus (BE) was diagnosed in seven patients (2%) and esophageal stricture in
one (0.2%). One hundred and four patients (24%) had hiatus hernia (HH), 16 (4%) gastric ulcers
and 45 (10%) duodenal ulcers. In multivariate analysis, male sex and HH were two independent risk
factors for the development of RE.
Conclusion: The prevalence of RE is low among patients undergoing endoscopy. Most of the
patients had a mild degree of esophagitis. BE and stricture were rarely seen. Male sex and HH were
risk factors of RE.
ª 2013 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Gastro esophageal reﬂux disease (GERD) is a common
chronic disorder prevalent in many countries.1 It is one of
the most prevalent diseases seen in Western countries.1 Pub-
lished studies indicate that the prevalence of GERD is lower
in the Asian population and the spectrum of the disease is
mild.2 A systematic review identiﬁed a 10–20% prevalence of
GERD (at least weekly heartburn and/or regurgitation) in
the western countries; while in Asia, the prevalence was at
<5%.3 It has been suggested that there is an increasing trend
in the prevalence of GERD over the last two decades and that
reﬂux disease is more common in Asian countries than previ-
ously recognized.4,5
Age, male sex, obesity, and hiatus hernia (HH) were the
purported risk factors for GERD.1 Changes in preference to
a more Westernized diet and lifestyle were considered respon-
sible for the increase in reﬂux disease in Asia.6 Epidemiologic
data from the Indian subcontinent, Africa, South America,
and the Middle East are sparse.1 There are no population-
based studies describing the prevalence of GERD in the
African countries.1
GERD is a condition which develops when the reﬂux of
stomach contents causes troublesome symptoms and/or com-
plications.7 Heartburn and regurgitation are the characteristic
symptoms of GERD. Patients with GERD symptoms may
have no obvious mucosal injury during endoscopic examina-
tion, whereas others with GERD symptoms demonstrate
esophageal injury such as erosions and ulcers.8 Therefore,
GERD can be subdivided into endoscopy-negative reﬂux dis-
ease or nonerosive reﬂux disease (NERD) and erosive esopha-
gitis or reﬂux esophagitis (RE).8,9
Esophageal complications of GERD are RE, hemorrhage,
stricture, Barrett’s esophagus (BE), and adenocarcinoma. BE
is an important, potentially pre-malignant complication of
GERD and is clearly associated with esophageal adenocarci-
noma.10 BE, which develops as a complication of chronic
GERD, is characterized by a change from the normal
squamous esophageal epithelium to columnar epithelium.
The major reason to evaluate patients with longstanding
GERD is to recognize BE. The possible role of GERD induced
RE leading to BE has not been clearly established, but possible
cellular injury and subsequent healing with columnar epithe-
lium has been hypothesized.10 Neither the frequency nor the
severity of heartburn is useful for the prediction of the pres-
ence of RE or BE.7,11Studying racial and geographic differences in GERD and
its complications are important as they highlight environmen-
tal or genetic inﬂuences in etiology and increase our under-
standing of the disease pathogenesis and management.1
The aim of the study was to determine the prevalence,
severity and risk factors of RE among patients undergoing
endoscopy in a secondary referral hospital in Egypt.
2. Materials and methods
This was a retrospective, hospital-based study carried out at
Bolak Eldakror Hospital over a 13-year period from January
2000 to January 2013. Bolak Eldakror Hospital is a second-
ary-care governmental hospital in Giza, Egypt. The hospital
serves a population of nearly one million. The gastrointestinal
endoscopy unit was set up in 1999. The endoscopy unit pro-
vides an open-access service and receives patients from outpa-
tient clinics and other hospitals in the area. Patients are mainly
with lower socioeconomic status. All patients presenting with
gastro-esophageal reﬂux symptoms (RS) were included in the
study. Ten gastroenterologists performed all endoscopies. Pro-
cedures were performed with well-trained competent endosco-
pists or supervised trainees. Endoscopic biopsy was done at the
discretion of the endoscopist. Pathological examination was
performed by two expert pathologists.
2.1. Deﬁnitions
Gastro-esophageal RS are deﬁned as heartburn with or with-
out acid regurgitation.11 RE is deﬁned as mucosal breaks in
the lower esophagus, as seen by endoscopy.12 Severity of
esophagitis was deﬁned based on endoscopic ﬁndings accord-
ing to the Savary-Miller grading system.13,14 Grade 1: single
or multiple erosions on a single fold. Erosions may be exuda-
tive or erythematous. Grade 2: multiple erosions affecting mul-
tiple folds. Erosions may be conﬂuent. Grade 3: multiple
circumferential erosions. Grade 4: ulcer, stenosis or esophageal
shortening. Grade 5: BE. Columnar epithelium on the distal
esophagus observed to rise proximally from the gastric plica-
tions and intestinal metaplasia and/or goblet cells found in
biopsy samples from these sites was considered as diagnostic
criterion for BE. NERD is deﬁned as no mucosal breaks in
the esophagus and the patients have typical RS.12 HH is de-
ﬁned as a circular extension of the gastric mucosa of two cm
or more above the diaphragmatic hiatus.15
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A total of 4477 patients underwent upper gastrointestinal
endoscopy between January 2000 and January 2013. Four
hundred and thirty-three patients were presenting with gas-
tro-esophageal RS (10% all upper gastrointestinal endoscop-
ies). Data on patients presenting with RS and scheduled for
upper gastrointestinal endoscopy were collected. Patients with
dysphagia, eosoniphilic esophagitis, esophageal candidiasis
and RE from gastric outlet obstruction were excluded.
2.3. Data recording and statistics
A standardized data collection form (sheet) was completed for
each patient. Recorded information included Patients’ charac-
teristics: demographic data (age and gender), smoking history,
drugs used (aspirin or non-steroidal anti-inﬂammatory drugs)
and alcoholic consumption. Clinical data included description
of gastro-esophageal RS (duration, frequency and intensity)
and the presence of acid regurgitation symptoms. Due to the
low education state of a big category of our patients, assess-
ment of heartburn intensity was classiﬁed into 3 grades (mild,
moderate and severe). Endoscopic ﬁndings and histopathology
were also recorded. Microsoft Access and Excel were used for
storage and analysis of the data. The endoscopic components
of the database included identiﬁcation of the presence of RE,
grade of esophagitis, stricture and BE. Targeted biopsies and
four-quadrant biopsies were obtained in patients with BE.
Endoscopic ﬁndings, such as HH, gastric ulcer, duodenal ulcer
were also assessed. Risk factors for the development of RE
were assessed. Patients were divided into two groups according
to the presence of esophagitis on upper gastrointestinal endos-
copy (patients with RE or NERD). Patients’ characteristics,
clinical features and endoscopic ﬁndings were compared.
Data from the patients was registered tabulated and statis-
tically analyzed using the Statistical Package for Social
Sciences (SPSS) program version 15 to calculate frequencies
and the v2 test or Fisher’s exact test. The v2 test was performed
to investigate the relationships between the rate of RE and pa-
tients‘ characteristics, clinical features and endoscopic ﬁndings.
The following variables were included: age (<60 or
P60 years); sex; current smoking; aspirin or non-steroidal
anti-inﬂammatory drugs (NSAIDs) intake; alcohol consump-
tion; Frequency of RS (daily, two to three times per week or
infrequent); Intensity of RS (mild, moderate or severe); acid
regurgitation symptoms; HH; gastric ulcer and duodenal ulcer.Table 1 Patients’ characteristics of the studied group.
Parameters Patients with RE (n= 106) Pa
Age
Mean ± SD 46 ± 15 years 45
P60 years 33 (31%) 76
<60 years 73 (69%) 25
Sex
Male 84 (79%) 17
Female 22 (21%) 15
Current smoking 48 (45%) 96
Aspirin or NSAIDs intake 28 (26%) 92
Alcohol consumption 3 (3%) 5 (A P value <0.05 was considered signiﬁcant. Those variables
found to be signiﬁcant by univariate analysis were subse-
quently assessed by a stepwise logistic regression method (mul-
ti-variate analysis) to identify independent demographic,
clinical and endoscopic factors predicting the presence of RE.
3. Results
A total of 433 patients presenting with gastro-esophageal RS
were assessed. Two hundred and ﬁfty-four patients (59%) were
male and 179 (41%) female. Ages ranged from 18 to 85 years,
mean 45 ± 15 years. One hundred and nine (25%) patients
aged P60 years. One hundred and forty-four patients (33%)
had a history of smoking, 120 (28%) were taking aspirin or
NSAIDs and 8 (2%) were consuming alcohol. The duration
of RS ranged from one month to 20 years, mean
21 ± 30 months. RS occurred daily in 146 patients (34%),
two to three times per week 45 (10%), infrequent 48 (11%)
and not recorded 194 (45%). RS were classiﬁed as mild in 42
patients (10%), moderate in 106 (24%), severe in 70 (16%)
and not recorded in 215 (50%). Ninety-nine patients (23%)
had acid regurgitation symptoms.
One hundred and six patients (24%) were found to have
RE. Ninety-eight of them (23%) showed grade 1, ﬁve (1%)
grade 2, two (0.5%) grade 3, and one (0.2%) grade 4. BE
was suspected in seven patients (2%) and histologically con-
ﬁrmed in ﬁve (1%) of these. BE was long-segment in three pa-
tients (1%) and short segment in four (1%). One patient
(0.2%) had esophageal stricture. One hundred and four pa-
tients (24%) had HH, 16 (4%) gastric ulcers and 45 (10%)
duodenal ulcers. Three hundred and twenty-seven patients
(76%) were found to have NERD.
A comparison of patients’ characteristics, clinical features
and endoscopic ﬁndings of patients with RE or NERD is
shown in Tables 1 and 2. Both groups of patients were with
similar mean age (46 and 45 years, P= 0.5). Male sex was pre-
dominant in patients with RE compared to those with NERD
(79% and 52%, respectively, P= 0.000). Smoking consump-
tion was signiﬁcantly higher in patients with RE than those
with NERD (45% and 29%, respectively, P= 0.003). Aspirin
or NSAIDs intake and alcohol consumption were not signiﬁ-
cantly different (P= 0.8 and 0.4, respectively). The duration
of RS was similar (22 and 20 months, P= 0.6). The available
data of frequency and intensity of RS revealed that both were
not signiﬁcantly different (P= 0.5 and 0.9, respectively). The
presence of acid regurgitation symptoms was not signiﬁcantlytients with NERD (n= 327) Total (n= 433) P value
± 15 years – 0.5
(23%) 109 (25%)
1 (77%) 324 (75%) 0.122
0 (52%) 254 (59%)
7 (48%) 179 (41%) 0.000
(29%) 144 (33%) 0.003
(28%) 120 (28%) 0.8
2%) 8 (2%) 0.4
Table 2 Clinical features* and endoscopic ﬁndings of the studied group.
Parameters Patients with RE (n= 106) Patients with NERD (n= 327) Total (n= 433) P value
Duration of RS (mean ± SD) 22 ± 30 months 20 ± 30 months – 0.6
Acid regurgitation symptoms 28 (26%) 71 (22%) 99 (23%) 0.3
Hiatus hernia 57 (54%) 47 (14%) 104 (24%) 0.000
Gastric ulcer 1 (1%) 15 (5%) 16 (4%) 0.08
Duodenal ulcer 12 (11%) 33 (10%) 45 (10%) 0.7
* Frequency and intensity of RS are not included in the table because of some missing data.
Table 3 Univariate and multi-variate analysis of risk factors of reﬂux esophagitis.
Factors Patients with RE (n= 106) Patients with NERD (n= 327) Univariate analysis Multivariate analysis
OR 95% CI P value OR 95% CI P value
Sex (male) 84 (79%) 170 (52%) 3.5 2.1–5.9 0.000 2.82 1.5–5.3 0.001
Current smoking 48 (45%) 96 (29%) 1.99 1.3–3.1 0.003 1.49 0.8–2.7 0.2
Hiatus hernia 57 (54%) 47 (14%) 6.9 4.2–11.3 0.000 7.4 4.3–12.7 0.0000
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with RE than in those with NERD (54% and 14%, respec-
tively, P= 0.000). Prevalence of gastric ulcer and duodenal ul-
cer was not signiﬁcantly different (P= 0.08 and 0.7,
respectively). Univariate and multi-variate analysis of risk
factors of RE are shown in Table 3.
4. Discussion
GERD is a common disease, especially in the Western coun-
tries. Endoscopy is a very valuable tool in the evaluation of
GERD. Based on the endoscopic ﬁndings, the patients were
divided into those with NERD or RE and BE. Endoscopic
ﬁndings in patients with GERD have ranged as widely as from
10% to 70%.16
RE and BE are common complications of GERD in the
Western countries. RE was reported in 62%, 49% and 34%
of patients with symptoms of gastro-esophageal reﬂux in stud-
ies from Finland, Spain and United States, respectively.17–19
BE was detected in 15–20% of those undergoing upper gastro-
intestinal endoscopy for symptoms of gastro-esophageal
reﬂux.19,20
Studies from the Asian countries have showed a low prev-
alence of RE and BE among patients with symptoms of gas-
tro-esophageal reﬂux. Also patients with RE had mild
esophagitis and severe esophagitis was seen rarely.2 RE was re-
ported in 17%, 23% and 20% of patients with symptoms of
gastro-esophageal reﬂux in studies from Turkey, Malaysia
and Japan, respectively.16,21,22 BE was detected in 2% of those
undergoing upper gastrointestinal endoscopy for symptoms of
gastro-esophageal reﬂux.16,21
A limited number of studies have reported on GERD and
its complications in the African countries. RE and BE was re-
ported in 45% and 10.6% of Sudanese patients with symptoms
of gastro-esophageal reﬂux.23 A South African study reported
a prevalence rate of RE of only 0.7% although the deﬁnition
of esophagitis was not provided.24 The data indicate that BE
is rare in Sub-Saharan African countries (South Africa, Ethio-
pia, Nigeria, Zimbabwe, Kenya, and Uganda).25 Clearly there
is recognizable potential for reporting bias based on differen-tials as compared to other areas of the world. This would in-
clude: access to care, patient expectations and willingness for
treatment, local resources, regional variations in diagnostic ap-
proaches, among other potential variables.1 Two studies from
Egypt reported that the prevalence of RE was 49.8% and 78%
in patients with symptoms of gastro-esophageal reﬂux and the
prevalence of BE was 7.3% and 9.9%.26,27
In the current study 433 patients with gastro-esophageal RS
undergoing endoscopy were assessed. RE was diagnosed in
24% of patients and most of the patients had a mild degree
of esophagitis representing grade 1 (93%) and grade 2 (5%).
Esophageal stricture was diagnosed in 0.2%. BE was suspected
in seven patients (2%) and histologically conﬁrmed in ﬁve
(1%) of these. No case of esophageal cancer was reported in
this study. Symptoms were unreliable indicators of the pres-
ence of RE. Risk factors of RE are analyzed and summarized
in Table 3. Univariate analysis identiﬁed male sex, current
smoking and HH as risk factors associated with RE. In mul-
ti-variable analysis, however, male sex (odds ratio
[OR] = 2.82, 95% conﬁdence interval [CI] = 1.5–5.3,
P= 0.001) and HH (OR= 7.4, 95% CI = 4.3–12.7,
P= 0.0000) were two independent risk factors for the devel-
opment of RE.
Complications of GERD include RE, stricture and BE.10
The importance of RE rests in its potential for masking under-
lying BE.28 BE, a condition clearly associated with adenocarci-
noma, is asymptomatic.29,30 Age >60 years old, male gender,
smoking, alcohol drinking, overweight and HH were identiﬁed
as risk factors associated with RE.22,31,32 RE and BE are com-
mon complications of GERD in the Western countries.16
However, Eastern countries represent different risk factors
for GERD such as eating habits, lower prevalence of obesity,
high rate of Helicobacter Pylori, and low parietal cell mass.16
For these reasons, the prevalence of these complications might
be different in developing and under-developed countries and
thus more data are needed.16
The current study revealed low prevalence of RE among
patients with gastro-esophageal RS who underwent upper gas-
trointestinal endoscopy. Most of the patients had a mild de-
gree of esophagitis. BE and stricture were rarely seen. Male
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(24%) and BE (1%) in the current study is consistent with the
studies conducted in Asia and different from the studies con-
ducted in Western countries. Attempts to explain these lower
rates in Asia usually cited lower body mass index (BMI), dif-
ferences in eating habits and genetic composition.16 The aver-
age BMI value for adults in Egypt is 26.7 and Egypt is one of
the countries which have the highest averages of BMI (P25)
and the highest prevalence of obese among low- and middle-in-
come countries (42.2%).33,34 Also the incidence of BE in the
West has risen rapidly in recent years as has adenocarcinoma
of the esophagus (the main complication of BE) and they are
beginning to rise in the Far East where they have traditionally
been less common than in America and Europe.35,36 These
changes are too rapid for the underlying genetic proﬁle to have
evolved. It would be more appropriate to emphasize the differ-
ences in eating habits (environmental factors) for the lower
rates found in the current study. The low prevalence of BE
indicates that guidelines from developed countries should be
adapted carefully in developing countries.
The prevalence of RE and BE in the current study (24%
and 1%) is lower than that reported in two studies from Egypt
(49.8%, 78%) and (7.3%, 9.9%).26,27 Both studies were con-
ducted in tertiary hospitals (university hospitals) with patients’
selection e.g. all patients had RS for at least three times weekly
for the last year in one study.26 Our study was conducted in a
secondary referral hospital during routine practice over a 13-
year period and most of the patients were managed in primary
care practice before referral. Limitations of the current study
include: This study was conducted in a secondary care govern-
mental hospital serving a low socio-economic district; lack of
assessment of extra esophageal symptoms; any treatment re-
ceived by patients before endoscopy; BMI and some data were
missing (frequency and intensity of RS). Further studies and
multi-center studies are recommended to assess the prevalence
of GERD and its complications in Egypt.5. Conclusion
The prevalence of RE is low among patients undergoing
endoscopy in a secondary referral hospital in Egypt. Most of
the patients had a mild degree of esophagitis. BE and stricture
were rarely seen. Male sex and HH were risk factors of RE.
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